Titlebook: Isolated Liver Perfusion for Hepatic Tumors; Karl J. Oldhafer,Hauke Lang,Rudolf Pichlmayr Conference proceedings 1998 Springer-Verlag Berl

miscreant

amputation

Are There Indications for Intraarterial Hepatic Chemotherapy or Isolated Liver Perfusion? The Case oiver perfusion adds to IAHC an extracorporal extraction and allows the use of higher doses of chemotherapy. Its efficacy has been suggested in small phase II trials; however, its relative complexity and the lack of clear demonstration of its efficacy compared to the most recent and effective systemi

使成核

BIBLE

難理解

Percutaneous Isolated Liver Chemoperfusion for Treatment of Unresectable Malignant Liver Tumors: Tecix patients died early; one of necrotizing pancreatitis and the other of hepatic arterial thrombosis. Both deaths were related directly to the hepatic arterial catheter. Excluding these two deaths, the treatments were well tolerated. The major side effects were mild to moderate chemical hepatitis an

Canary

Juvenile

Isolated Hepatic Perfusion with Tumor Necrosis Factor , and Melphalan: Experimental Studies in Pigs cluding controls, as demonstrated by liver enzyme assays and histology. There was no significant hemodynamic, cardiopulmonary hemotological, or renal toxicity. In the phase I clinical study there was leakage in one patient (cumulative leakage 20%). There were three perioperative deaths (one possibly

預(yù)感

Munificent

Ordeal

Are There Indications for Intraarterial Hepatic Chemotherapy or Isolated Liver Perfusion? The Case os, when no resection is feasible, and when no active systemic chemotherapy is available. Liver metastases from colorectal cancer represent one of the best indications, and many trials have demonstrated that IAHC is an efficient treatment. Some of these trials were randomized and have demonstrated th